Vera Therapeutics VERA Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Vera Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The official record: Vera Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vera Therapeutics's accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vera Therapeutics's accrued expenses?
- Vera Therapeutics (VERA) reported accrued expenses of $31.24M in Q1 2026.
- How has Vera Therapeutics's accrued expenses changed year-over-year?
- Vera Therapeutics's accrued expenses increased by 1046.0% year-over-year, from $2.73M to $31.24M.
- What is the long-term trend for Vera Therapeutics's accrued expenses?
- Over 5 years (2020 to 2025), Vera Therapeutics's accrued expenses has grown at a 126.0% compound annual growth rate (CAGR), from $535K to $31.56M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.